Year: 2018

  Patented Medicine Prices Review Board: Exploring the Impact of Proposed Price Reforms Original Broadcast: Thursday, October 11th 2018 1:00pm – 2:00pm ET This engaging webinar will help you learn more about the Patented Medicine Prices Review Board and the impact of their proposed price review reforms. The webinar was moderated by 3Sixty Public Affairs’ Bill Dempster, who was joined by a panel of experts.

  Liver Cancer 101: Causes, Treatments, Innovations & Access Original Broadcast: Thursday, September 4th 2018 1:00pm – 2:00pm ET CCSN was joined by Dr. Mamatha Bhat (Hepatologist at University Health Network in Toronto), Dr. Amol Mujoomder (Interventional Radiologist at London Health Sciences Centre) and Dr. Gregory Powell (HCC patient & founder of Shock Trauma Air Rescue Services Foundation) for a webinar surrounding Hepatocellular Carcinoma (HCC),

The Canadian Cancer Survivor Network (CCSN) held its 7th annual legislative reception and breakfast at Queen’s Park on October  3, 2018. Throughout the reception, MPPs had an opportunity to hear from patients, caregivers, advocates and health experts to learn more about biologics & biosimilars. Speakers at the reception included The Honourable Christine Elliott, Deputy Premier and Minister of Health and Long-Term Care (pictured top of page

Statistics show that fewer people are dying from major cancers across Canada. Despite this, statistics regarding survival rates for primary liver cancer (hepatocellular carcinoma or HCC) are heading in the wrong direction. An estimated 2,500 new cases of liver cancer are diagnosed, with an estimated 1,200 deaths occurring annually, according to data from the 2017 Canadian Cancer Society report. In response to these alarming statistics,

Despite being the number one cancer killer in Canada, outcomes in lung cancer lag behind other cancers. Lung cancer is the most commonly diagnosed cancer in Canada. It kills more than 21,000 Canadians every year — more people than colorectal, breast, and prostate cancers combined. Lung cancer is in fact many diseases, requiring different treatment approaches and therapeutic options. Scientific advancements are transforming the treatment

Sharon Dixon, who lives in Edmonton, Alberta, was diagnosed with stage 4 squamous cell carcinoma and had very aggressive reconstructive jaw surgery in 2006. She is a 12-year cancer survivor, will be retiring this year, and is turning 65 years old. In a year of milestone accomplishments, Sharon’s goal is to raise $10,000 which will be donated directly to the Canadian Cancer Survivor Network for